LIOTHYRONINE SODIUM (Northwind Pharmaceuticals)
Welcome to the PulseAid listing for the LIOTHYRONINE SODIUM drug offered from Northwind Pharmaceuticals. This l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Northwind Pharmaceuticals |
NON-PROPRIETARY NAME: | LIOTHYRONINE SODIUM |
SUBSTANCE NAME: | LIOTHYRONINE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-12-29 |
END MARKETING DATE: | 0000-00-00 |
LIOTHYRONINE SODIUM HUMAN PRESCRIPTION DRUG Details:
Item Description | LIOTHYRONINE SODIUM from Northwind Pharmaceuticals |
LABELER NAME: | Northwind Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(ug/1) |
START MARKETING DATE: | 2014-12-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51655-122_05548cb8-6ee3-47a4-960e-6b2d576240aa |
PRODUCT NDC: | 51655-122 |
APPLICATION NUMBER: | ANDA200295 |
Other LIOTHYRONINE SODIUM Pharmaceutical Manufacturers / Labelers: